Case Report
A Unique Case of Lemierre Syndrome Associated with Thrombophilia in an Adult and the Role of Anticoagulation
Table 1
Thrombophilia screen.
| | Day 4 | Day 80 | Normal value | Units |
| PT | 17.4 | 46.4 | 11–15 | seconds | APTT | 62.4 | 47 | 22–35 | seconds | PTT mix | 38.5 | 38.7 | 28–38 | seconds | Thrombin time | 76.9 | 22.9 | 16–22 | seconds | Reptilase time | 17.6 | | 14–18 | seconds | Protein C activity | 17 | 10 | 70–140 | percent | Protein S activity | 68 | 10 | 58–128 | percent | Factor V HR2 | ND | ND | — | — | Factor V L M | HZ | HZ | — | — | Factor VIII | 2.01 | 1.05 | 0.6–1.5 | Units/mL | Factor X | 0.78 | 0.1 | 0.7–1.5 | Units/mL | Dil RVVT | 1.4 | — | 0.9–1.3 | ratio | A T III activity | 46 | 97 | 80–120 | percent | HLN | Pos | Neg | — | — | TTI | 1.7 | 2.2 | 0.7–1.3 | ratio | d APC R | 1.8 | 1.6 | 2.1–30 | ratio | ACL IgG | 13.3 | 11.9 | 0.0–23 | GPL units | ACL IgM | 17 | 8.2 | 0.0–11 | MPL units |
|
|